Abstracts16-01ArcticLine: A New Cryo Ablation Catheter for the creation of Linear Lesions16-02Plasma transforming growth factor β1-mediated atrial fibrosis to predict the recurrence of atrial fibrillation after surgical maze procedure16-03Prognostic significance of cytokine concentrations in the serum to assess the effectiveness of the pulmonary vein isolation16-04Association between biomarkers of fibrotic turnover, PR interval and electro-anatomical substrate in AF patients undergoing radiofrequency catheter ablation16-05Galectin 3 as a risk factor recurrence of atrial fibrillation in patients with metabolic syndrome16-06The impact of left ventricular diastolic dysfunction for the very late recurrence after the multiple atrial fibrillation ablations16-07Long-Term Results of Catheter Ablation for Persistent Atrial Fibrillation in Very Young Adults – Lessons from a 4-year follow up16-08Quality of life in patients after radiofrequency ablation of the pulmonary veins16-09Real-world impact of ablation in patients with atrial fibrillation and flutter: an observational study based on healthcare administrative databases16-10The relationship between a severity of sleep-disordered breathing of atrial fibrillation ablation candidates and the late recurrence after single and multiple atrial fibrillation ablations16-11Long-term follow-up of atrial fibrillation ablation in a large cohort: earlier timing of ablation improves outcome16-12Clinical Outcome of Catheter Ablation for Persistent Atrial Fibrillation Which Acts as Paroxysmal Atrial Fibrillation after Antiarrhythmic Drug Therapy16-13Comparision of Outcomes of Atrial Fibrillation Ablation Procedures between an Octagenerian cohort of patients and an Young-Old cohort of patients16-14Relationship between the long-term results of pulmonary vein isolation and left atrial bipolar voltage during atrial fibrillation rhythm16-15SMART SF: PAF Ablation With THERMOCOOL SMARTTOUCH® SF Catheter16-16First evaluation of contact force during atrial fibrillation ablation using a novel robotic system (AMIGO®) combined to a force-sensing catheter. A single centre experience16-17Contact-force guided single catheter approach for pulmonary vein antrum isolation: procedural feasibility16-18Collective impacts of power, contact force and ablation time on ablation effect of atrial fibrillation16-19Real-world Data of Persistent AF Ablation With CF-Sensing Catheter16-20Impact of Contact-Force guided Catheter Ablation for Atrial Fibrillation without usage of Esophageal Temperature Monitoring16-21Ablation index correlates with impedance drop during catheter ablation of atrial fibrillation16-22Quantification of the ablation zone after wide area circumferential pulmonary vein isolation applying a new high-density mapping system16-23Endocardial voltage mapping of pulmonary veins with a new ultra high-resolution electroanatomical mapping system to evaluate atrial myocardial extensions16-24Identification of Heterogeneous Intra-Atrial Conduction Delay in Paroxysmal AF Patients by Dynamic Electrophysiological Characterization16-25Left atrial conduction delay as a marker of electroanatomical scar in patients undergoing pulmonary vein isolation: results from the SCAR-AF study16-26Electrical Remodeling Does not Reproducibly Mirror Structural Change on Atrial MRI16-27Percutaneous Left Atrial Appendage Closure with WATCHMAN device: results from the TRAPS Registry16-28Residual leaks after left atrial appendage closure in correlation to the shape of ostium and lending zone16-29Accidental finding of a thrombus formation on a left atrial appendage occluder device during long-term follow-up16-30Radiofrequency ablation of right-sided accessory pathways in children: how have 3-D mapping systems and cool-tip catheters changed success, fluoroscopy time and recurrence?16-31Successful ablation of parahisian atrial tachycardia and pathway mediated tachycardia via non coronary cusp16-32Reason of corrected ST segment depression during a narrow QRS complex tachycardia (AVNRT and AVRT)16-33Long-term outcomes of ischemic ventricular tachycardia submitted to catheter ablation16-34Specific CT features indicative of fibrofatty replacement are associated with local conduction delay in ARVC confirmed by endocardial and epicardial electroanatomical mapping16-35Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy – Experience of a Tertiary Care Center16-36Analysis of Complications in Anterior versus Inferior Access to the pericardial space in patients with Epicardial Ventricular Tachycardia16-37Interhospital differences in pacemaker implantation rate in a Norwegian health region16-38Permanent pacing for complete atrioventricular block in central Africa16-39Immediate Management following Cardiac Implantable Electronic Device procedures; Wide Variation in Practice from a UK Survey16-40Changes in activation of coagulation cascade in patients with implanted devices16-41Effects of radiation therapy on cardiac implantable electronic devices - Evaluation of a standardized safety protocol16-42Anxiety and depression in patients with heart rhythm disorder16-43Hospitalization for syncope and orthostatic hypotension predicts incident cardiovascular disease in older middle-aged patients16-44Pacemaker Detected Sleep Apnea Predicts New Onset Atrial Fibrillation16-45Implantable loop recorders: the experience of a center16-46Ten year follow up of a Chagasic cohort with implanted cardiac pacemakers. Single center experience16-47Long-Term Follow-up Results for Ictal Asystole in Temporal Lobe Epilepsy. Is there need for additional pacemaker therapy?16-48Does drug discontinuation in patients treated with temporary pacemaker reduce permanent pacemaker implantation?16-49Assessing the Safety of Implantable Cardioverter-Defibrillator Reuse16-50Electronic Article Surveillance Systems Remain a Potential Threat to CIED Patients16-51Evolution of ICD lead parameters after continuous-flow LVAD implantation16-52Ventricular Reduction (Dor Procedure) Cures Ventricular Arrhythmias and eliminates the need for ICD's in Ischemic Cardiomyopathy16-53ICD patients' compliance with driving restrictions: associated factors16-54Heart failure patient wishes regarding future improvements in cardiac implantable device remote monitoring16-55The Need for changes in ICD programming after ICD intervention in patients under remote monitoring- results of the German Advance Analytics Device Database16-56Sleep Apnea Syndrome in a Multicentric Study on Patients with Device Remote Monitoring System16-57The impact of remote monitoring of implanted cardioverter–defibrillator (ICD) and cardiac resynchronization therapy device (CRT–D) patients on healthcare costs: 3-year follow-up16-58Feasibility of automated detection of sleep apnea using implantable pacemakers and Defibrillators16-59Long-term experience of remote monitoring in a population with cardiac implantable electronic devices for the treatment of ventricular tachyarrythmias16-60A New Approach to analyze ICD therapy Efficacy. Single-Centre Experience of Discovery™ Link TachyMed (Medtronic, USA)16-61CIEDs-related endocarditis incidence among a single electrophysiology center: results from a long term prospective case-based study16-62Comparison between the first and second generation Evolution Sheath16-63Impact of ICD lead on the system durability and long-term outcomes after ICD lead extraction16-64Multi-Center Experience with the Spectranetics TightRail Lead Extraction System16-65Characterization of a new clinical phenomena: Shock following cardiac implantable electronic device extraction16-66Survival of patients with biventricular devices after device infection16-67Correlation of QRS Duration and serum apoptosis markers with ventricular histological remodelling in patients with severe heart failure and ischaemic and dilated cardiomyopathy16-68Right ventricular dysfunction complicates prediction of response to cardiac resynchronization therapy by mechanical dyssynchrony parameters: combined clinical-modeling approach16-69Upgrading CRT systems from previous pacemakers and ICD's, assessing the clinical outcomes16-70Is atrial fibrillation responsible for less response to cardiac resynchronization therapy in heart failure patients?16-71Impact of fragmented QRS in the outcome of CRT patients16-72Magnitude of QRS reduction after biventricular pacing identifies responders to Cardiac Resynchronization Therapy16-73Long term outcomes of cardiac resynchronization therapy with a defibrillator according to QRS duration in patients with left bundle branch block16-74Prognostic impact of QRS axis deviation in patients treated with cardiac resynchronization therapy16-75Clinical outcomes and QRS duration change in the late responders of cardiac resynchronization therapy16-76Assessing the value of novel biomarkers in the prediction of clinical outcomes after cardiac resynchronization therapy16-77Cardiac Resyncrhonization Therapy and survival according to sex16-78Sex and Cardiac Resynchronization Therapy16-79Vitamin D deficiency predicts adverse outcomes after cardiac resynchronization therapy16-80Non-invasive testing cannot identify a typical substrate for life-threatening re-entry VTs in athletes16-81Prevalence of early repolarisation in children16-82Noninvasive Epicardial and Endocardial Mapping of Ventricular Ectopic Arrhythmias16-83Association of frequent ventricular premature complex > 20% and stroke symptoms without a prior diagnosis of stroke or transient ischemic attack16-84Deceleration capacity discriminates arrhythmic from mortality risk in primary prevention ICD recipients16-85Efficacy and safety of quinidine in patients with Brugada syndrome16-86Prevalence and prognosis role of wide QRS and of QRS “narrower than normal”9-01The multicenter TAVI Brazilian Registry & the need for permanent pacemaker following transcatheter aortic valve implantation. Incidence, predictors and clinical outcomes9-02First Report On Communicating Leadless Anti-Tachycardia Pacemaker And Subcutaneous Implantable Defibrillator - The Next Step In Cardiac Rhythm Management9-03Aair vs. dddr in sick sinus syndrome. extended follow-up in danpace9-04Worldwide Clinical Experience of the Retrieval of Leadless Cardiac Pacemakers9-05Both Selective And Non-Selective His Pacing Preserve Left Ventricle Activation9-06Complications associated with pacemaker therapy: Systematic literature review and meta-analysis9-07Feasibility of Extravascular Pacing with a Novel Substernal Electrode Configuration: Results from the Multi-center Substernal Pacing Acute Clinical Evaluation (SPACE) Trial9-08Comparison of trans-esophageal echocardiography and FDG PET/CT in the diagnosis of implanted device lead endocarditis22-01Epicardial ablation in Brugada syndrome. Insights from a prospective Registry study of 50 consecutive patients22-02Results of the Pulmonary vein RE-isolation as a routine Strategy: a SUccess Rate Evaluation (PRESSURE) randomised controlled trial22-03Thoracoscopic Ganglionic Plexus Ablation does not Improve Outcome in Advanced Atrial Fibrillation. The AFACT trial22-04The impact of underlying heart rhythm on the incidence of pericardial effusion after left atrial appendage occlusion using Watchman – Data from the EWOLUTION registry22-05Combining LAA closure and catheter ablation for long-term stroke prevention: multicenter registry results of feasibility, efficacy, and safety during implant and 30 days follow-up22-06Individualized Cryoballoon Energy pulmonary vein isolation guided by real Time PV recordings, the randomized “ICE–T” Trial29-01Optical Tissue Interrogation Catheter that Provides Real-Time Monitoring of Catheter-Tissue Contact and RF Lesion Progression using NADH Fluorescence29-02Optogenetic termination of anatomical reentry in rat myocardial slices29-03Optogenetically-induced microfoci of oxidative stress increase pro-arrhythmic risk29-04Specific accumulation of phospholamban in and around the nucleus of cardiomyocytes modulates perinuclear/nuclear calcium dynamics29-05Aberrant sodium influx causes spontaneous atrial fibrillation and mitochondrial injury in a novel transgenic mouse29-06Inducibility of Atrial Fibrillation After Epicardial Injection of the new pharmaceutical composition containing botulinum toxin into epicardial fat pads29-07Real time Imaging of Lesion Formation During Radiofrequency Ablation Using Intracardiac Myocardial Elastography29-08Application of SILAC-based mass spectrometry for determining the phosphoproteome in continuously or interval-paced HL-1 cardiomyocytes216-71Reduction of recurrence of atrial fibrillation after electrical cardioversion by Dabigatran-etexilate216-72Association of non-LDL-cholesterol with risk of recurrence of atrial fibrillation after successful electrical cardioversion216-73QT/RR regression correlation coefficient as non-invasive risk stratification tool216-74Tpeak-Tend interval dispersion as a marker of ventricular fibrillation inducibility after therapeutic hypothermia in subjects with aborted arrhythmic sudden cardiac death216-75Intraoperative arrhythmias in children with congenital heart disease: transient, innocent events?216-76Cognitive Behavioral Therapy improves symptoms and quality of life in paroxysmal atrial fibrillation49-01VT isthmus characteristics and conduction velocities: Insight from High Density mapping49-02Arrhythmia dynamics in heterogeneous fibrotic tissue is determined by the regions with the highest degree of fibrosis49-03Arrhythmogenic Features of Channels of Surviving Myocytes in Post-Infarct Patients With and Without Spontaneous VT49-04Substrate Differences With Voltage Mapping During Right Ventricular Pacing Versus Sinus Rhythm49-05Defining arrhythmogenic ventricular scar using time- and voltage-domain mapping (V-T-mapping): a new approach to ventricular tachycardia channel localization during sinus rhythm49-06Using electromechanical wave imaging, a novel non-invasive ultrasound imaging tool to detect endocardial versus epicardial arrhythmia origins56-01A computational model of rat atrial monolayers56-02Spatially-discordant alternans phase islands promote arrhythmogenesis56-03Increased arrhythmia vulnerability in KChIP2 knock-out mice is explained by different spatial dispersion of ventricular repolarization and location of cardiac stimulation56-04Myocardial expression of non-desmosomal molecules in arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to dilated cardiomyopathy and healthy controls56-05Outcome of Catheter Ablation of Atrial Fibrillation in Patients with Latent Heart Failure and Preserved Left Ventricular Ejection Fraction56-06Long-Term Results of Catheter Ablation for Paroxysmal Atrial Fibrillation in Very Young Adults – A 5-Year Follow-Up Study56-07Left atrial appendage volume as a predictor for atrial fibrillation recurrence after catheter ablation56-08Prevalence and consequences of collateral findings detected by computed tomography in patients undergoing pulmonary vein isolation for atrial fibrillation56-09Modified Transseptal Puncture Technique to Achieve Success and Ensure Safety in all Patients56-10Periprocedural factors associated with outcome in paroxysmal atrial fibrillation. Is “clean pulmonary vein isolation” enough?56-11The impact of simple protocol changes in improving safety of Catheter Ablation for Atrial Fibrillation: experience from a tertiary centre in England56-12Long-term outcome after catheter ablation of atrial fibrillation and predictors of good arrhythmia control56-13Anesthesia in ablation procedures: differences between public and private centers. The French Electra Survey56-14Long term results of catheter ablation after surgical treatment of atrial fibrillation: Electrophysiological analysis and ablation strategies56-15Staged Hybrid Ablation for Longstanding Persistent Atrial Fibrillation56-16Box Lesion Ablation of Atrial Fibrillation Pre Cardiopulmonary Bypass in High Risk Ischemic/Valvular Cardiomyopathy Patients: Early and Long Term Results56-17Two step ablation of atrial fibrillation in patients with coronary artery bypass grafting surgery56-18Use of the Rythmia ™ system for mapping atrial flutter in univentricular heart after Fontan procedure56-19Mechanism and outcomes of catheter ablation for ventricular tachycardia in adults with repaired congenital heart disease56-20Radiofrequency ablation safety and efficacy in early childhood56-21Atrial fibrillation ablation targeting rotors: quantification and most frequent locations56-22The Relationship Between Stable Rotors and Obstructive Sleep Apnea in Patients with Long-Standing Persistent AF56-23Left Atrial Bipolar Voltage Map in a Large AF-Cohort: A prospective, systematic study and its fundamental findings56-24Usefulness of fibrosis quantification by Magnetic Resonance with Late Gadolinium Enhancement in prediction of recurrence after atrial fibrillation ablation56-25Magnetic resonance imaging analysis comparing preexisting and ablation-induced late gadolinium enhancement characteristics in patients with atrial fibrillation56-26Left atrial appendage occlusion for stroke prevention in atrial appendage occlusion for stroke prevention in atrial fibrillation: contemporary commissioning through evaluation experience from the United Kingdom56-273D rotation angiography to guide LAA closure56-28Can the Origin be Identified Using Pace Mapping in Patients with Non-sustained or Difficult-to-induce Focal Atrial Tachycardia?56-29Functional permanent 2:1 atrioventricular block treated with cardioneuroablation:Casereport56-30Clinical impact of slow-pathway ablation in patients with clinical on-off tachycardia symptoms; from a standpoint of symptomatic improvement56-31High mortality after Ablation of Ventricular Tachycardia in patients with Dilated Cardiomyopathy56-32Long-Term Benefit of First-Line Peri-ICD Implant VT-Substrate Ablation in Secondary Prevention Patients56-33Catheter Ablation of frequent Ventricular Tachycardia after interventional Left Ventricular Restoration56-34Success, limitation and medium term follow up of epicardial VT ablation procedures in a large single centre cohort56-35Etiology of bradycardia and risk of sudden cardiac death in children with permanent pacemakers56-36Permanent cardiac pacing in iatrogenics bradyarrhythmias or in patients with potential reversibles causes56-37Eight years experience in permanent pacemaker implantation after open heart surgery56-38Pacemaker implantation after cardiac surgery: are we implanting to soon?56-39Resumption of AV Node conduction in Post-TAVR patients who receive pacemakers56-40Utility of Permanent-Temporary Pacemaker in the Management of Patients Undergoing Transcatheter Aortic Valve Implantation56-41Use of Remote Monitoring in the management of ICD end-of-life and the replacement strategy: preliminary data from the DECODE registry56-42Characteristics of VF episodes in ICD patients transmitted by a new remote monitoring system – First results of the German CareLink Analytics Device Database56-43Importance of a monitoring zone in the diagnosis of arrhythmias in ICD carriers: retrospective evaluation of a long-term remote monitoring program56-44Evaluation of a High Pass Filter Designed to Reduce Oversensing in the S-ICD56-45MR scanning access in MR-conditional pacemaker and implantable cardioverter defibrillator population: preliminary results from the Really ProMRI study56-46Efficacy and safety of internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients56-47Impact Of The Introduction Of A Standardised ICD Programming Protocol: Real-World Data From A Single Centre56-48Safety and efficacy of subcutaneous ICDs: A single-center long-term results56-49Manufacturer change at the time of ICD replacement: Italian survey and data from the DECODE study56-50Does ICD longevity vary by manufacturer?56-51A modified technique for device implantation using axillary subpectoral approach56-52Investigation Of The Utility Of The Audible Alert In Current Generation Medtronic Implantable Cardioverter-Defibrillators56-53Single Center Experience with extraction of Active Fixation Coronary Sinus Leads56-54The effect of tricuspid regurgitation and its changes on the response to Cardiac Resynchronization Therapy56-55Device-Related Infective Endocarditis in Cardiac Resynchronization Therapy Recipients – Single Center Registry With Over 2500 Person-Years Follow-Up56-56Biventricular Device infection, what is new?56-57Prognosis of second CRT implantation after complete device extraction56-58Influence of selected factors on the electrical lead failure in patients referred for TLE procedures56-59Response to cardiac resynchronization therapy and outcomes in hemodialysis patients56-60Cardiac Resynchronization Therapy in Patients with Renal Dysfunction: factors related to efficacy and outcomes56-61A Clinical Risk Score to Predict All-Cause Mortality in Patients Receiving Cardiac Resynchronization Therapy: A Retrospective Cohort Study56-62Response to cardiac resynchronization: the impact of baseline autonomic nervous system function56-63Perfusion and metabolic scintigraphy with radiolabeled fatty acid in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy56-64Mortality in patients implanted with cardiac resynchronisation therapy with or without a defibrillator56-65The use of different methods for the selection of patients with non-ischemic cardiomyopathy for cardiac resynchronization therapy56-66The impact of different CRT response criteria in outcomes56-67Morbidity and Mortality with Cardiac Resynchronization Therapy with Pacing (CRT-P) versus with Defibrillation (CRT-D) in Octogenarian Patients in a Real-World Setting56-68Outcomes of upgrading octogenarian patients with previous pacemakers and ICDs to CRT systems. Assessment of clinical response56-69Frailty syndrome as a valuable factor which influence the survival, mortality and mean life expectancy in patients qualified for CRT56-70CRT Survey II56-71Long-term Cardiac Resynchronization Therapy Reduces T-wave Alternans in Patients with Cardiomyopathy56-72Electrical Dyssynchrony and Optimization Potential in Patients with and without Class I Indications for Cardiac Resynchronization Therapy56-73Concomitant Structural Heart Disease does not predict Tachycardiomyopathy in a Large Series of Patients with Atrial Fibrillation56-74Diagnostic value of the electrocardiogram in arrhythmogenic left ventricular cardiomyopathy56-75High-grade atrioventricular block in acute coronary syndromes: predictors and in-hospital prognosis56-76External loop recording for 7 days detects more patients with atrial fibrillation compared to 2-day Holter recording in patients with ischemic stroke or transient ischemic attack56-77Adapting the threshold for atrial fibrillation detection in insertable cardiac monitors based on evidence of irregular sinus rhythm56-78Development and validation of an atrial fibrillation knowledge questionnaire56-79Electrical storm as phenotypic manifestation of malignant repolarization syndrome56-80Enhanced Antiarrhythmic Effects of Dofetilide in a Largely African American Population56-81The Atrial Fibrillation Termination Patterns56-82Comparison of four formulas of adjusting QT interval for the heart rate in young elite athletes56-83Prediction of atrial fibrillation after ischemic stroke or transient ischaemic attack using PR interval56-84Prevalence of atrio-ventricular conduction delay in pediatric athletes69-01The role of cardiac magnetic resonance imaging in patients undergoing ablation for ventricular tachycardia: Defining the substrate and visualizing the outcome69-02Anatomical Based Prediction of Left VS Right Outflow Tract Origin of Premature Ventricular Contractions69-03Safety, Long-Term Outcomes, and Predictors of Recurrence after First-Line Combined Endoepicardial Ventricular Tachycardia Substrate Ablation in Arrhythmogenic Cardiomyopathy. A Prospective Multiceter Study69-04High resolution mapping with Rhythmia system for ventricular tachycardia ablation69-05ARVC and myocarditis can coexist?Comparative study between CMR and EBM69-06Combined analysis of unipolar and bipolar voltage mapping identifies recurrences after unmappable scar-related ventricular tachycardia ablation69-07Signal-Averaged Electrocardiography as a Noninvasive Tool for Evaluating the Outcomes after Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients with Ischemic Heart Disease: Reappraisal of an Old Tool73-01Evaluation of the diagnostic process of arrhythmogenic cardiogenetic disease: how to improve the yield?73-02Impact of lead aVR for exclusion of arrhythmogenic cardiomyopathy73-03Supraventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy73-04Cardiac phenotype and prognosis of patients with mutations in NKX2.5 gene73-05Focal Hypermetabolic Left Ventricular Cardiomyopathy: An Underdiagnosed Life-threatening Arrhythmogenic Disease89-01Stricter Criteria for Left Bundle Branch Block Diagnosis do not Improve Patient Selection for CRT89-02Vectorcardiographic QRS area identifies delayed left ventricular lateral wall activation determined by electroanatomic mapping in candidates for cardiac resynchronization therapy89-03The Impact of Left Ventricular Scar on the Acute Hemodynamic Improvement with Multisite Left Ventricular Pacing89-04Gender Effects of CRT in Patients with QRS Duration <130 ms in EchoCRT89-05Validation of NOGA-derived assessment of left ventricular function against MRI89-06Assessment of vectorcardiographic parameters of the paced QRS complex as prediction of acute hemodynamic response in CRT patients89-07Multipoint pacing via a quadripolar left ventricular lead: Preliminary results from an Italian Registry89-08Coronary resynchronisation and the differing effects of epicardial and endocardial pacing on coronary wave energetics96-01Spatial Heterogeneity of Cx43 and Its Non-phosphorylated Form Is an Arrhythmogenic Substrate of Polymorphic Ventricular Tachycardias in Compensated Cardiac Hypertrophy in Rats96-02Catecholamine-Induced Degradation of Vascular Gap Junctions Suggests Mechanism for Stress Cardiomyopathy96-03Can a modification of gap junction conductance reduce the risk of malignant tachyarrhythmias? Insights from a computational model96-04An MEA-Based Stem Cell-Cardiomyocyte Coculture Model for Studying Electrical Signal Propagation after Stem Cell Transplantation96-05A simple risk score to predict the recurrence of atrial fibrillation after a first catheter ablation procedure96-06Atrial Fibrillation Ablation in Stand-Alone Atrial Flutter Final and Long-term results from the Prospective Randomized Trial (Triple A)96-07Usefulness of left atrial 3D mapping using intracardiac echocardiography within left atrium for pulmonary vein isolation96-08Short-term amiodarone treatment for atrial fibrillation after catheter ablation induces a transient thyroid dysfunction: Results from the placebo-controlled randomized AMIO-CAT trial96-09Safety profile of atrial fibrillation ablation versus amiodarone therapy: a comparison in a large cohort96-10Low prevalence of pulmonary vein reconnection and active arrhythmogenic sources at first repeat procedure after stepwise catheter ablation for long-standing persistent atrial fibrillation96-11Absence of left ventricular structural changes by delayed-enhancement magnetic resonance imaging in patients with arrhythmia-induced cardiomyopathy due to long-standing persistent atrial fibrillation96-12Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis96-13Non-vitamin K Antagonist Oral Anticoagulant and Warfarin as Periprocedural Oral Anticoagulation Therapy of Catheter Ablation for Atrial Fibrillation: J-CARAF Study96-14Peri-atrial Fat Volume as a Predictor of Outcome in Hybrid Atrial Fibrillation Ablation96-15Atrial tachyarrhythmias in patients after surgical CryoMaze ablation procedure96-16Three year follow up of the convergent hybrid AF ablation for persistent AF96-17Atrial tachycardias in patients with long-standing persistent atrial fibrillation undergoing thoracoscopic epicardial RF ablation96-18Localization of reconduction after epicardial thoracoscopic RF ablation procedures in patients with persistent atrial fibrillation96-19Totally thoracoscopic ablation with post-procedural endocardial confirmation for Treatment of lone atrial fibrillation: Propensity matched comparison with catheter ablation96-20Hybrid ablation for long-standing persistent AF. A 2 stage non-concomitant approach using the Cobra Fusion Device and catheter ablation - single-centre experience96-21Detection of Very Low Voltage Critical Signals In Scarred Human Atria with A New Automated Ultra-high Resolution Mapping System96-22Comparison of a novel tool for automatic measurement of left atrial scar burden with visual estimation in patients undergoing ablation of atrial fibrillation96-23Impact of Atrial fibrillation on the Voltage of Bipolar Signals from the Left Atria96-24Association of Left Atrial Electroanatomical Substrate and Risk of Thromboembolic Events in Patients with Atrial Fibrillation96-25Role of 3D Rotational Angiography in the morphological characterization of the left atrial appendage aimed at closure interventions96-262-D versus 3-D transesophageal echocardiography for the percutaneous left atrial appendage occlusion in atrial fibrillation patients96-27Dual decremental limbs in a reciprocating tachycardia- an electrophysiological problem or the lack of it?96-28Focal atrial tachycardia originating from the septal mitral annulus in young adults: tricks and traps96-29Relationship between left atrial contact force and pacing threshold96-30Ultra-high Density Mapping With Multielectrode Catheter vs Conventional Point by Point Mapping for Ventricular Tachycardia Substrate Ablation96-31Clinical Impact of J Waves on the Recurrence of Ventricular Tachycardia after Radiofrequency Catheter Ablation in Patients with Post-infarct Ventricular Tachycardia Irrespective of QRS Widths96-32Functional Substrates Are Associated with Ventricular Arrhythmia Recurrence Following Ablation96-33Cardiac Magnetic Resonance-Guided Scar Dechanneling. Influence on Acute and Long-Term Outcomes96-34Importance and Difference of Variability of Paced QRS Duration Caused by Right Ventricular Apex Pacing and Septal Pacing in Patients with Atrioventricular Block96-35Long term follow-up of the hisian pacing: a single centre experience96-36Sheath-guided Permanent Pacemaker Lead Delivery to Right Ventricular Septum: A Newly Developed Long-type Peel Off Sheath96-37Clinical Perforation Risk Reduction of a Novel 6F Lead96-38Intermediate and long term outcomes of permanent LV coronary sinus pacing without an RV lead- two LV leads may be better than one!96-39Newly diagnosed atrial fibrillation after dual chamber pacemakers implantation: the importance of right ventricle pacing site96-40The Endocardiac Position of Implantable Cardioverter-Defibrillator Leads Does Not Result in More Appropriate Shocks96-41ICD efficacy in midseptal vs. apical RV lead positions. A subanalysis from the prospective randomized SPICE trial96-42Comparison of lead failure rates between DF-1 and DF-4 ICD leads in clinical practice96-43Anatomical Inputs for the Development of a Novel Extravascular ICD Lead Implant Procedure96-44Atrial sensing stability in single-lead ICD with floating dipole: preliminary observations from the THINGS registry96-45Pacing and Sensing Performance of Non-Contact Electrodes in the Substernal Space in Swine96-46Electrical storm in ICD patients due to ventricular tachycardia or ventricular fibrillation: clinical characteristics and prognosis96-47Retrospective Analysis of Patients with Chagas Heart Disease and Implantable Cardioverter Defibrillator9

enthalten in: Europace | 2016

von Avitall, B. | Jeon, Y. | Kolasa, J. | +98